دورية أكاديمية

High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.

التفاصيل البيبلوغرافية
العنوان: High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.
المؤلفون: O'Day, Steven J., Boasberg, Peter D., Kristedja, Tim S., Martin, Maureen, Wang, He-Jing, Fournier, Patricia, Cabot, Myles, DeGregorio, Michael W., Gammon, Guy, O'Day, S J, Boasberg, P D, Kristedja, T S, Martin, M, Wang, H J, Fournier, P, Cabot, M, DeGregorio, M W, Gammon, G
المصدر: Cancer (0008543X); Aug2001, Vol. 92 Issue 3, p609-619, 11p
قاعدة البيانات: Complementary Index
الوصف
تدمد:0008543X
DOI:10.1002/1097-0142(20010801)92:3<609::AID-CNCR1361>3.0.CO;2-U